PTAB LEAP Oral Hearing Boot Camp
August 20 to September 17, 2021
Location
Credits
No CLE
Registration
The PTAB’s Legal Experience and Advancement Program (LEAP) is designed to encourage new oral advocacy opportunities for patent attorneys and agents that have three or fewer substantive oral arguments in any federal tribunal (including PTAB) and seven or fewer years of experience as a licensed attorney or agent. The program allows PTAB judges to grant up to 15 minutes additional argument time, upon request for oral hearing participation by a LEAP-eligible practitioner.
In furtherance of the LEAP initiative, the PTAB and AIPLA are jointly organizing an oral hearing virtual boot camp in which practitioners will be able to present an argument before sitting PTAB judges and obtain invaluable feedback post-argument. The boot camp will be held mainly on Fridays beginning August 20. The current schedule is below:
- August 20, 2021, time TBD: Information session for participants, with details regarding mock argument logistics & PTAB oral hearing practice tip
- September 8, 2021, 10am – 11am ET: (Optional) LEAP Office Hours
- September 8, 2021, 12pm – 1pm ET: Panel discussion “The Night Before Argument: Preparing for your AIA argument” (this session will be open to the public)
- September 10, 2021, 1pm – 4pm ET: AIPLA/LEAP AIA Trials Mock Argument
- September 17, 2021, 12pm – 1pm ET: AIA Oral Argument Encore, in which experienced practitioners argue the same case (this session will be open to the public)
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.